期刊文献+

山东省耐利福平结核分枝杆菌rpoB基因突变的研究 被引量:6

RpoB gene mutations of rifampin?resistant Mycobacterium tuberculosis in Shandong Province
下载PDF
导出
摘要 目的分析山东省利福平耐药结核菌株rpoB基因突变特点。方法本研究为回顾性调查,135株样本分别取自1997、2000及2003年的流行病学调查和医院的临床样本。采用PCR直接基因测序法分析rpoB基因突变。结果135株结核菌中,60株为利福平耐药菌株,其中55株(91.7%)rpoB基因的利福平耐药决定区(RRDR)有突变。突变频率依次为密码子531(60.0%),526(29.1%)和516(7.3%)。1株耐药菌同时发生了少见的3个密码子(511,515,518)的多核苷酸突变。75株敏感菌株中,仅3株(4.0%)有突变,均发生在密码子533,包括一个新发现的突变基因型CTG(Leu)→ATG(Met)。结论来自山东省结核菌中,利福平耐药表型与rpoB基因突变的符合率为94.1%,并提示密码子533突变与利福平耐药表型相关性较低。 Objective To investigate gene mutations in the rifampin (RIF) resistance determining region (RRDR) of rpoB gene in Mycobacterium tuberculosis (MTB) isolates from Shandong Province, China. Method60 RIF-resistant and 75 RIF-susceptible MTB isolates collected from over 30 counties of Shandong Province in 1997, 2000, and 2003 were analyzed by direct DNA sequencing. Results Fifty five (91.7%) of 60 RIF - resistant isolates were found missense mutations in RRDR of rpoB gene. The most common mutations occurred at codon 531 (60.0%), 526 (29.1%) and 516 (7.3%) respectively. One isolate presented multiple mutations at codons 511, 515, 518 simultaneously. Only 3 (4.0%) of 75 RIF- susceptible isolates showed mutations at codon 533 with one novel mutation type (CTG→ATG). Conclusion The agreement rate between RRDR mutations of rpoB gene and RIF resistance among 135 MTB isolates from Shandong Province is 94.1% (127/135). Mutations at codon 533 were not associated with RIF resistance.
出处 《中国防痨杂志》 CAS 2005年第5期289-292,共4页 Chinese Journal of Antituberculosis
基金 美国国立卫生研究院(NIH)基金资助项目(NO1-A0-02738)
  • 相关文献

参考文献12

  • 1潘晞,何国钧.耐多药结核病的研究及进展[J].中华结核和呼吸杂志,2000,23(2):119-123. 被引量:113
  • 2Pablos-Mendez A, Raviglione MC, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance[J]. N Engl J Med. 1998; 338:1641-1649.
  • 3Herrera L, Jimenez S, Valverde A, et al. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents[J], 2003;21:403-408.
  • 4McClure W R, Cech C L. On the mechanism of rifampicin inhibition of RNA synthesis. J Biol Chem 1978; 253:8949-8956.
  • 5Qian L, Abe C, Lin TP, et al. RpoB genotypes of mycobacterium tuberculosis Beijing family isolates from East Asian Countries[J]. J Clin Microbiol, 2002; 40:1091-1094.
  • 6Mani C, Selvakumar N, Narayanan S, et al. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India[J]. J Clin Microbiol, 2001; 39:2987-2990.
  • 7Kapur V, Li LL, Iondanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas[J]. J Clin Microbiol, 1994;32:1095-1098.
  • 8Espinal MA, Laszlo A, Simonsen L,et al., Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance[J]. N Engl J Med. 2001;344:1294-1303.
  • 9International Union Against Tuberculosis and Lung Disease. The public health service national tuberculosis reference laboratory and the national laboratory network, Paris: IUATLD,1998.
  • 10Ohno H, Koga H, Kohno S, et al., Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan[J]. Antimicrob Agents Chemother. 1996;40:1053-1056.

二级参考文献6

  • 1Mdluli K,Science,1998年,280期,1607页
  • 2Sreevatsan S,Antimicrob Agents Chemother,1997年,41卷,600页
  • 3Sreevatsan S,Antimicrob Agents Chemother,1997年,41卷,636页
  • 4Sreevatsan S,Proc Nat Acad Sci SUA,1997年,94期,9869页
  • 5Sreevatsan S,Chemophere,1996年,40卷,1024页
  • 6Dooley S W,Ann Int Med,1992年,117卷,257页

共引文献112

同被引文献103

  • 1乐军,曾而良,谢建平,李瑶,梁莉,王洪海.中国耐多药结核分枝杆菌临床分离株rpoB基因突变特点[J].Acta Genetica Sinica,2004,31(12):1332-1336. 被引量:23
  • 2JIAO Wei-wei,Mokrousov Igor,SUN Gui-zhi,LI Mo,LIU Jia-wen,Narvskaya Olga,SHEN A-dong.Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing,China[J].Chinese Medical Journal,2007(9):814-819. 被引量:39
  • 3黄振宇,范学工.210株结核分枝杆菌利福平耐药基因rpoB突变特征研究[J].中国人兽共患病学报,2007,23(6):548-551. 被引量:15
  • 4Wade MM, Zhang Y. Mechanisms of drug resistance in Myco- bacterium tuberculosis. Front Biosci, 2004, 9:975 994.
  • 5Bolotin S, Alexander IX2, Chedore P, et al. Molecular charac- terization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada. J Antimicrob Chemother, 2009, 64 (2) .. 263-266.
  • 6Louw GE, Warren RM, Gey van Pittius NC, et al. A balan- cing act: efflux/influx in mycobacterial drug resistance. Anti- microb Agents Chemother, 2009, 53(8): 3181-3189.
  • 7Somoskovi A, Parsons LM, Salfinger M. The molecular basisof resistance to isoniazid, rifampin, and pyrazinamide in Myco- bacterium tuberculosis. Respir Res, 2001, 2(3): 164-168.
  • 8Ma X, Wang H, Deng Y, et al. rpoB Gene mutations and mo lecular characterization of rifampin-resistant Mycobacterium tu- berculosis isolates from Shandong Province, China. J Clin Mi crobiol, 2006, 44(9): 3409 3412.
  • 9Leonard B, Coronel J, Siedner M, et al. Inter- and intra-assay reproducibility of mieroplate Alamar blue assay results for iso- niazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and eapreomycin drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol, 2008, 46(10): 3526-3529.
  • 10Gupta AK, Katoch VM, Chauhan DS, et al. Microarray ana- lysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microb Drug Resist, 2010, 16(1): 21-28.

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部